Nitric oxide and immune response in infection control of Caseous Lymphadenitis / Óxido nítrico e resposta imune no controle de infecção da Linfadenite Caseosa

This study aimed to evaluate aspects of host immune response using an experimental infection model of Corynebacterium pseudotuberculosis (CP) in C57/Black6 wild-type and knockout for nitric oxide (KO-NO) mice. 28 mice were evaluated: 4 wild-type controls; 10 wild-type infected with CP; 4 KO-NO controls; 10 KO-NO infected with CP. Infection procedures were carried out by intraperitoneal inoculation using 107. Infected C57/Black6 KO-NO mice began to die after the 5° day post-inoculation, up until the 14º day. Neutrophils were found in increased numbers in the infiltrate of KO-NO murine peritoneal cavities. Examination of splenic tissue revealed an accumulation of lymphocytes, predominantly CD8 T-cells, in experimental animal groups. KO-NO animals were found to have a predominance of granulomas 7 days post-inoculation, primarily in the lymph nodes. In addition, greater amounts of bacteria were recovered from the mesenteric lymph nodes of KO-NO mice. There was no statistically significant difference in the levels of total IgG and its subclasses 14 days post-inoculation between KO-NO and wild groups. The results suggest the importance of nitric oxide in the process of controlling CP infection, as KO-NO animals were observed to be markedly more affected by infection with this bacterium.(AU)

O objetivo deste estudo foi avaliar os aspectos da resposta imune do hospedeiro, mediante o uso de um modelo experimental de infecção de Corynebacterium pseudotuberculosis (CP) em camundongos C57/Black6 do tipo selvagem e em C57/Black6 knockout para o óxido nítrico (KO-NO). Foram avaliados 28 camundongos: quatro controles de tipo selvagem; 10 do tipo selvagem infectados com CP; quatro controles KO-NO; e 10 KO-NO infectados com CP. A infecção foi realizada via intraperitoneal, usando-se 107. Os animais C57/Black6 KO-NO infectados começaram a vir a óbito no quinto dia pós-inoculação, o que aconteceu até o 14º dia. Um número maior de neutrófilos foi encontrado na sua cavidade peritoneal. O exame do baço revelou um acúmulo de linfócitos, predominantemente células T CD8, nos grupos de animais experimentais. Nos animais KO-NO, foi observada a presença de granulomas, sete dias pós-inoculação, principalmente nos gânglios linfáticos. Além disso, uma maior quantidade de bactérias foi detectada dos linfonodos mesentéricos desses animais. Não houve diferença estatisticamente significante nos níveis séricos IgG total e em suas subclasses aos 14 dias pós-inoculação nos grupos KO-NO e selvagem. Os resultados obtidos sugerem a importância do óxido nítrico no processo de controle da infecção por CP.(AU)

Sleep disturbances in hepatitis C patients undergoing treatment: minisleep questionnaire as a screening tool.

AIM: Sleep disturbances are frequently reported by patients with chronic hepatitis C virus (HCV) during treatment with interferon (IFN) α plus ribavirin. Poor sleep quality is related to the onset of depression and impaired quality of life in patients receiving treatment. The aims of this study were to apply the Mini Sleep Questionnaire (MSQ) as a screening tool to assess the self-reported sleep quality and the prevalence of sleep disorders. METHODS: We conducted a transversal, observational, descriptive study comprising 41 subjects with HCV, divided into two groups, treatment (N.=16) and control (N.=25). A structured questionnaire was used to collect sociodemographic and clinical data and the MSQ was applied to assess the sleep quality. A Chi-square test was applied to compare sleep quality between groups. RESULTS: Significant differences between groups in the classification of sleep quality were observed (P<0.05). The group of patients under treatment presented higher frequency of sleep disorders (63%) when compared to the control group (12%). Additionally, the apnea domain was the most impacted. CONCLUSION: This study identified a higher prevalence of sleep disorders and self-reported poor sleep quality in HCV patients under treatment. The MSQ may be useful as a screening tool for sleep disorders in HCV patients during the treatment with IFN-α plus ribavirin.